Antiganglioside antibodies in sub types of guillain-barre syndrome in an Indian population

A. K. Meena, A. D. Archana, G. C. Reddy, D. Ramakrishna, Pragna Rao

Research output: Contribution to journalArticle

Abstract

Antiganglioside antibody tests for immune-mediated neuropathy are now widely available. They can identify subsets of patients within the large group of idiopathic neuropathies that have lacked specific clinical definition. The aim was to study the subtypes of Guillian Barre Syndrome based on the presence of type of antiganglioside antibodies and to correlate these with the clinical features. Sera from 73 patients with GBS which included the subtypes of Acute Inflammatory Demyelinating Polyneuropathy (AIDP), Acute Motor Axonal Neuropathy (AMAN), acute motor and sensory axonal neuropathy (AMSAN) and Miller Fisher Syndrome (MFS) were examined for the presence of IgG and IgM (GMl, GM2, GM3, GD1A, GD1B, GT1B, GQ1B) antiganglioside antibodies using qualitative in vitro kit. In GBS, IgG GMl (59%) and IgM GMl (25%) were positive in maximum number of cases. In subgroup AMAN, IgG (GMl and GD1B) were positive in 53% of cases, IgM GMl was positive in 50% of cases. Two patients of AMAN who had a previous history of gastroenteritis were positive for all IgG antibodies. In the subgroup AIDP, IgG GT1B and IgM GMl were positive in 28 and 18%, respectively. Multiple types of antiganglioside antibodies were associated with the subtypes of GBS in the population from South India. AMAN variant was commonly associated with antibodies as compared to other variants. Antibodies associated with subtype AMAN were IgG GMl, GD1B and IgM GMl. AIDP variant was associated with IgG GT1B and IgM GMl. The assay may be useful for rapid screening of GBS sera for antibodies to multiple gangliosides.

Original languageEnglish
Pages (from-to)138-142
Number of pages5
JournalJournal of Medical Sciences
Volume10
Issue number5
Publication statusPublished - 2010

Fingerprint

Guillain-Barre Syndrome
Immunoglobulin G
Immunoglobulin M
Antibodies
Population
Miller Fisher Syndrome
Gangliosides
Gastroenteritis
Serum
India

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Meena, A. K., Archana, A. D., Reddy, G. C., Ramakrishna, D., & Rao, P. (2010). Antiganglioside antibodies in sub types of guillain-barre syndrome in an Indian population. Journal of Medical Sciences, 10(5), 138-142.
Meena, A. K. ; Archana, A. D. ; Reddy, G. C. ; Ramakrishna, D. ; Rao, Pragna. / Antiganglioside antibodies in sub types of guillain-barre syndrome in an Indian population. In: Journal of Medical Sciences. 2010 ; Vol. 10, No. 5. pp. 138-142.
@article{5447367ef4ae49dd9af7e7e9cec52507,
title = "Antiganglioside antibodies in sub types of guillain-barre syndrome in an Indian population",
abstract = "Antiganglioside antibody tests for immune-mediated neuropathy are now widely available. They can identify subsets of patients within the large group of idiopathic neuropathies that have lacked specific clinical definition. The aim was to study the subtypes of Guillian Barre Syndrome based on the presence of type of antiganglioside antibodies and to correlate these with the clinical features. Sera from 73 patients with GBS which included the subtypes of Acute Inflammatory Demyelinating Polyneuropathy (AIDP), Acute Motor Axonal Neuropathy (AMAN), acute motor and sensory axonal neuropathy (AMSAN) and Miller Fisher Syndrome (MFS) were examined for the presence of IgG and IgM (GMl, GM2, GM3, GD1A, GD1B, GT1B, GQ1B) antiganglioside antibodies using qualitative in vitro kit. In GBS, IgG GMl (59{\%}) and IgM GMl (25{\%}) were positive in maximum number of cases. In subgroup AMAN, IgG (GMl and GD1B) were positive in 53{\%} of cases, IgM GMl was positive in 50{\%} of cases. Two patients of AMAN who had a previous history of gastroenteritis were positive for all IgG antibodies. In the subgroup AIDP, IgG GT1B and IgM GMl were positive in 28 and 18{\%}, respectively. Multiple types of antiganglioside antibodies were associated with the subtypes of GBS in the population from South India. AMAN variant was commonly associated with antibodies as compared to other variants. Antibodies associated with subtype AMAN were IgG GMl, GD1B and IgM GMl. AIDP variant was associated with IgG GT1B and IgM GMl. The assay may be useful for rapid screening of GBS sera for antibodies to multiple gangliosides.",
author = "Meena, {A. K.} and Archana, {A. D.} and Reddy, {G. C.} and D. Ramakrishna and Pragna Rao",
year = "2010",
language = "English",
volume = "10",
pages = "138--142",
journal = "Journal of Medical Sciences (Faisalabad)",
issn = "1682-4474",
publisher = "Asian Network for Scientific Information",
number = "5",

}

Meena, AK, Archana, AD, Reddy, GC, Ramakrishna, D & Rao, P 2010, 'Antiganglioside antibodies in sub types of guillain-barre syndrome in an Indian population', Journal of Medical Sciences, vol. 10, no. 5, pp. 138-142.

Antiganglioside antibodies in sub types of guillain-barre syndrome in an Indian population. / Meena, A. K.; Archana, A. D.; Reddy, G. C.; Ramakrishna, D.; Rao, Pragna.

In: Journal of Medical Sciences, Vol. 10, No. 5, 2010, p. 138-142.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antiganglioside antibodies in sub types of guillain-barre syndrome in an Indian population

AU - Meena, A. K.

AU - Archana, A. D.

AU - Reddy, G. C.

AU - Ramakrishna, D.

AU - Rao, Pragna

PY - 2010

Y1 - 2010

N2 - Antiganglioside antibody tests for immune-mediated neuropathy are now widely available. They can identify subsets of patients within the large group of idiopathic neuropathies that have lacked specific clinical definition. The aim was to study the subtypes of Guillian Barre Syndrome based on the presence of type of antiganglioside antibodies and to correlate these with the clinical features. Sera from 73 patients with GBS which included the subtypes of Acute Inflammatory Demyelinating Polyneuropathy (AIDP), Acute Motor Axonal Neuropathy (AMAN), acute motor and sensory axonal neuropathy (AMSAN) and Miller Fisher Syndrome (MFS) were examined for the presence of IgG and IgM (GMl, GM2, GM3, GD1A, GD1B, GT1B, GQ1B) antiganglioside antibodies using qualitative in vitro kit. In GBS, IgG GMl (59%) and IgM GMl (25%) were positive in maximum number of cases. In subgroup AMAN, IgG (GMl and GD1B) were positive in 53% of cases, IgM GMl was positive in 50% of cases. Two patients of AMAN who had a previous history of gastroenteritis were positive for all IgG antibodies. In the subgroup AIDP, IgG GT1B and IgM GMl were positive in 28 and 18%, respectively. Multiple types of antiganglioside antibodies were associated with the subtypes of GBS in the population from South India. AMAN variant was commonly associated with antibodies as compared to other variants. Antibodies associated with subtype AMAN were IgG GMl, GD1B and IgM GMl. AIDP variant was associated with IgG GT1B and IgM GMl. The assay may be useful for rapid screening of GBS sera for antibodies to multiple gangliosides.

AB - Antiganglioside antibody tests for immune-mediated neuropathy are now widely available. They can identify subsets of patients within the large group of idiopathic neuropathies that have lacked specific clinical definition. The aim was to study the subtypes of Guillian Barre Syndrome based on the presence of type of antiganglioside antibodies and to correlate these with the clinical features. Sera from 73 patients with GBS which included the subtypes of Acute Inflammatory Demyelinating Polyneuropathy (AIDP), Acute Motor Axonal Neuropathy (AMAN), acute motor and sensory axonal neuropathy (AMSAN) and Miller Fisher Syndrome (MFS) were examined for the presence of IgG and IgM (GMl, GM2, GM3, GD1A, GD1B, GT1B, GQ1B) antiganglioside antibodies using qualitative in vitro kit. In GBS, IgG GMl (59%) and IgM GMl (25%) were positive in maximum number of cases. In subgroup AMAN, IgG (GMl and GD1B) were positive in 53% of cases, IgM GMl was positive in 50% of cases. Two patients of AMAN who had a previous history of gastroenteritis were positive for all IgG antibodies. In the subgroup AIDP, IgG GT1B and IgM GMl were positive in 28 and 18%, respectively. Multiple types of antiganglioside antibodies were associated with the subtypes of GBS in the population from South India. AMAN variant was commonly associated with antibodies as compared to other variants. Antibodies associated with subtype AMAN were IgG GMl, GD1B and IgM GMl. AIDP variant was associated with IgG GT1B and IgM GMl. The assay may be useful for rapid screening of GBS sera for antibodies to multiple gangliosides.

UR - http://www.scopus.com/inward/record.url?scp=77955533659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955533659&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 138

EP - 142

JO - Journal of Medical Sciences (Faisalabad)

JF - Journal of Medical Sciences (Faisalabad)

SN - 1682-4474

IS - 5

ER -